Stay updated with breaking news from Nasdaq Cinc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Brokerages expect CinCor Pharma, Inc. (NASDAQ:CINC – Get Rating) to announce earnings per share of ($0.50) for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for CinCor Pharma’s earnings, with the highest EPS estimate coming in at ($0.44) and the lowest estimate coming in at ($0.59). The business is scheduled to […]
CinCor Pharma (NASDAQ:CINC – Get Rating) posted its earnings results on Tuesday. The company reported ($15.71) EPS for the quarter, missing the Zacks’ consensus estimate of ($1.56) by ($14.15), MarketWatch Earnings reports. NASDAQ CINC traded up $0.09 on Thursday, hitting $15.39. 344 shares of the company traded hands, compared to its average volume of 247,779. […]
CinCor Pharma Inc (NASDAQ:CINC – Get Rating) shares gapped down before the market opened on Wednesday following a dissappointing earnings announcement. The stock had previously closed at $15.77, but opened at $15.01. CinCor Pharma shares last traded at $14.98, with a volume of 1,078 shares traded. The company reported ($15.71) EPS for the quarter, missing […]
BOSTON, Jan. 06, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on developing...